Of the remaining 57 patients (21.1%) who did not meet the JSOG 2024 criteria, 36 (63.2%) were additionally diagnosed with PCOS under the Rotterdam/IEBG 2023 criteria by applying elevated serum AMH (level 2). Here, AMH is linked to polycystic ovary syndrome.